Abbott's own clinical data, meanwhile, showed 84.6% sensitivity in the same group. “Equally as important, these data show that if a patient has no symptoms and they have a negative result, BinaxNOW will give the right answer 96.9% of the time,” the company said, referring to the test's measure of specificity.